It may also be an individual sensitivity reaction
Semaglutide is not a crash diet that works fast and then fails
They can only enter the market by either (1) waiting for all relevant patents to expire, (2) designing around the formulation patents with a different but bioequivalent formulation, or (3) challenging the patents in court as invalid or not infringed
However, theres limited research on the optimal dosage and how they compare to GLP-1 medications
These guidelines often emphasise evidence-based practice, patient safety, and the importance of considering individual patient characteristics and medical history when making treatment decisions

Abbreviations ADVANCE: action in diabetes and vascular disease AMI: acute myocardial infarction BID: twice daily bpm: beats per minute CI: confidence interval CVOT: cardiovascular outcome trial ELIXA: Evaluation of LIXisenatide in Acute coronary syndrome FIGHT: Functional Impact of GLP-1 for Heart Failure Treatment GLP-1 RA: glucagon-like peptide-1 receptor agonist HF: heart failure HR: heart rate LAR: long-acting release LEADER: Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results LIVE: Effect of LIraglutide on left VEntricular function in chronic heart failure patients with and without type 2 diabetes LS: least squares PK: pharmacokinetic QD: once daily QW: once weekly SE: standard error T2DM: type 2 diabetes mellitus References Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR